Improving Human Papillomavirus (HPV) Vaccination in the Postpartum Setting
- PMID: 27476162
- PMCID: PMC5510873
- DOI: 10.1007/s10900-016-0230-6
Improving Human Papillomavirus (HPV) Vaccination in the Postpartum Setting
Abstract
Although the HPV vaccine has been shown to be highly effective in preventing cervical dysplasia, vaccination rates remain low. The objective of this study was to assess the effectiveness of an electronic medical record (EMR) prompt on HPV vaccination rates in the postpartum setting. We conducted a pre-post intervention study among postpartum women ages 18-26 seen at an outpatient clinic from 09/01/2012-08/31/2013 (pre-intervention) and from 10/01/2013-03/31/2014 (post-intervention). The intervention was a drop-down menu that was inserted into the EMR postpartum note template inquiring about the patient's HPV vaccination status and whether or not the vaccine was administered at that visit. HPV vaccination uptake was compared pre and post-intervention. Of the 278 postpartum visits during the study period, 241 were eligible for analysis. There was a significant increase of the HPV vaccine uptake, from 1.2 % (2/173) among pre-intervention visits to 26.5 % (18/68) among post-intervention visits (p < 0.001). After adjusting for age, ethnicity, insurance, and religion, HPV vaccination was significantly higher at postpartum visits during the intervention period, with an adjusted OR = 93.49 [95 % CI 15.29-571.52]. Among visits in which the vaccine was not given, HPV vaccination was not discussed in 46 % and patients refused the vaccine in 40 % of visits. An EMR prompt in the postpartum note could be an effective way to promote HPV vaccination in the postpartum setting. It will likely take a combination of strategies to optimize vaccination uptake.
Keywords: Electronic medical record; Human papillomavirus; Immunizations; Vaccinations.
Figures
Similar articles
-
Evaluation of an Inpatient Postpartum Human Papillomavirus Immunization Program.Obstet Gynecol. 2020 Nov;136(5):1006-1015. doi: 10.1097/AOG.0000000000004097. Obstet Gynecol. 2020. PMID: 33030866 Free PMC article.
-
Success of an EMR-Driven Postpartum Intervention to Improve HPV Vaccination Rates.J Community Health. 2020 Jun;45(3):446-451. doi: 10.1007/s10900-019-00755-1. J Community Health. 2020. PMID: 31659600
-
Impact of Electronic Point-of-Care Prompts on Human Papillomavirus Vaccine Uptake in Retail Clinics.Am J Prev Med. 2018 Dec;55(6):822-829. doi: 10.1016/j.amepre.2018.06.027. Epub 2018 Oct 19. Am J Prev Med. 2018. PMID: 30344033 Free PMC article.
-
Human papillomavirus vaccine in adolescent women: a 2012 update.Curr Opin Obstet Gynecol. 2012 Oct;24(5):305-10. doi: 10.1097/GCO.0b013e3283567005. Curr Opin Obstet Gynecol. 2012. PMID: 22781077 Review.
-
EMR-Based Interventions on HPV Vaccination Initiation, Completion, and Receiving the Next Dose: A Meta-Analytic Review.Vaccines (Basel). 2024 Jul 3;12(7):739. doi: 10.3390/vaccines12070739. Vaccines (Basel). 2024. PMID: 39066377 Free PMC article. Review.
Cited by
-
Evaluation of an Inpatient Postpartum Human Papillomavirus Immunization Program.Obstet Gynecol. 2020 Nov;136(5):1006-1015. doi: 10.1097/AOG.0000000000004097. Obstet Gynecol. 2020. PMID: 33030866 Free PMC article.
-
Success of an EMR-Driven Postpartum Intervention to Improve HPV Vaccination Rates.J Community Health. 2020 Jun;45(3):446-451. doi: 10.1007/s10900-019-00755-1. J Community Health. 2020. PMID: 31659600
-
Improving Preventive Care for Children With Sickle Cell Anemia: A Quality Improvement Initiative.Pediatr Qual Saf. 2020 Dec 28;6(1):e379. doi: 10.1097/pq9.0000000000000379. eCollection 2021 Jan-Feb. Pediatr Qual Saf. 2020. PMID: 33409431 Free PMC article.
-
Using a Patient Navigator to Improve Postpartum Care in an Urban Women's Health Clinic.Obstet Gynecol. 2017 May;129(5):925-933. doi: 10.1097/AOG.0000000000001977. Obstet Gynecol. 2017. PMID: 28383374 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Human papillomavirus-associated cancers – United States, 2004-2008. Morbidity and Mortality Weekly Report. 2012;61:258–261. - PubMed
-
- Singh G, Miller B, Hankey B, Edwards B. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer. 2004;101:1051–1057. - PubMed
-
- Kahn J, Lan D, Kahn R. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstetrics and Gynecology. 2007;110:87–95. - PubMed
-
- Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalant human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recommendations and Reports. 2007;56(RR02):1–24. - PubMed
-
- Kjaer SK, Sigurdsson K, Iversen OE, et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prevention Research. 2009;2:868–878. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical